Understanding seroprevalence of dengue virus and its health surveillance impacts

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 506725

Grant search

Key facts

  • Disease

    Dengue
  • start year

    2024
  • Known Financial Commitments (USD)

    $4,393.39
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Selemon Anabel
  • Research Location

    Canada
  • Lead Research Institution

    University of Calgary
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Seroprevalence studies are imperative to estimate the true level of dengue virus infection in susceptible areas and provide necessary insights informing vaccination strategies. However, this research is scattered and decentralized, therefore difficult to apply to public health solutions. This research project aims to: a) centralize and synthesize global dengue seroprevalence studies through a systematic review and b) pilot some early exploratory analyses in region-focused dengue seroprevalence. The ultimate goal is to contribute valuable foundational insights on meta-analyzing arbovirus and dengue seroprevalence and will form the basis of further impactful work in integrated global dengue surveillance approaches. The student will work within the Centre for Health Informatics' SeroTracker team at the University of Calgary. SeroTracker is an internationally recognized initiative that monitors, combines, synthesizes, and presents all COVID-19 seroprevalence information available globally. This student will expand SeroTracker to a new global health concern surrounding arbovirus (specifically tracking seroprevalence of Dengue Fever).